Skip to main content
Top
Published in: AIDS and Behavior 10/2023

18-04-2023 | Smoking and Nicotine Detoxification | Original Paper

Feasibility, Acceptability, and Preliminary Effects of a Video-Based Intervention for Smoking Cessation Among People with HIV in Kathmandu, Nepal: A Single-Armed Pilot Study

Authors: Krishna C. Poudel, Kalpana Poudel-Tandukar, Ram Chandra Silwal, Bimal Sharma Chalise, Elizabeth R. Bertone-Johnson, Damon J. Vidrine

Published in: AIDS and Behavior | Issue 10/2023

Login to get access

Abstract

Despite the evidence of the disproportionate burden of tobacco use among people with HIV (PWH), little effort has been made to design and test smoking cessation interventions for PWH in resource-limited countries. We assessed the feasibility, acceptability, and preliminary effects of a video-based smoking cessation intervention consisting of eleven 3-8-minute sessions among PWH in Nepal, a lower-middle-income country. Guided by the phased-based model, our 3-month intervention focused on setting the quit date, smoking cessation, and abstinence maintenance. We screened 103 PWH over three weeks for our single-arm trial, with 53 considered eligible and 48 recruited (91%). Forty-six participants watched all video clips, while two watched 7–9. All participants were retained at a 3-month follow-up. The 1-week point prevalence abstinence (self-report supported with expired carbon monoxide levels < 5ppm) at 3-month follow-up was 39.6%. Most (90%) participants reported “very much” or “much” comfort with watching the videos on their smartphones, and all would recommend the intervention to other PWH who smoke. Overall, our pilot trial demonstrated the feasibility, acceptability, and high-level efficacy of the video-based smoking cessation intervention highlighting its potential for scaling up in Nepal and other resource-limited countries.
Literature
10.
go back to reference WHO. Tobacco, WHO Fact Sheet N 339. Geneva: World Health Organization; 2015;:23. WHO. Tobacco, WHO Fact Sheet N 339. Geneva: World Health Organization; 2015;:23.
11.
go back to reference UNAIDS. UNAIDS Data 2017. Geneva: Joint United Nations Programme on HIV/AIDS 2017. UNAIDS. UNAIDS Data 2017. Geneva: Joint United Nations Programme on HIV/AIDS 2017.
13.
go back to reference Maziak W, Eissenberg T, Klesges RC, Keil U, Ward KD. Adapting smoking cessation interventions for developing countries: a model for the Middle East. Int J Tuberc Lung Dis. 2004;8(4):403–13.PubMed Maziak W, Eissenberg T, Klesges RC, Keil U, Ward KD. Adapting smoking cessation interventions for developing countries: a model for the Middle East. Int J Tuberc Lung Dis. 2004;8(4):403–13.PubMed
14.
go back to reference Fiore MC, Baker TB et al. Jaén CR, Baker TB Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville,MD: U.S. Department of Health and Human Services. Public Health Service. May2008.;:23. Fiore MC, Baker TB et al. Jaén CR, Baker TB Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville,MD: U.S. Department of Health and Human Services. Public Health Service. May2008.;:23.
17.
Metadata
Title
Feasibility, Acceptability, and Preliminary Effects of a Video-Based Intervention for Smoking Cessation Among People with HIV in Kathmandu, Nepal: A Single-Armed Pilot Study
Authors
Krishna C. Poudel
Kalpana Poudel-Tandukar
Ram Chandra Silwal
Bimal Sharma Chalise
Elizabeth R. Bertone-Johnson
Damon J. Vidrine
Publication date
18-04-2023
Publisher
Springer US
Published in
AIDS and Behavior / Issue 10/2023
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-023-04062-8

Other articles of this Issue 10/2023

AIDS and Behavior 10/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine